Board MeetingOutcome of Board Meeting
Alkem Labs' Board approved Q3 & 9M consolidated results.
Alkem Laboratories LimitedALKEM · Filed with the exchange
Q3 revenue grew 11% YoY to ₹3,736.8 Cr, with Net Profit at ₹636 Cr.
Declared interim dividend of ₹43/share.
Also acquiring majority stake in medical device firm Occlutech.
No comments yet. Be the first.